King Faisal Specialist Hospital, Riyadh – United Arab Emirates
About Dr. Saadiya Khan
Dr. Saadiya Khan is a Consultant Pediatric Hematologist/Oncologist and Bone Marrow Transplant specialist, serving as a leading Pediatric Hematology / Oncology specialist in Riyadh, Saudi Arabia. Her practice focuses on leukemia, lymphoma, sickle cell disease, and pediatric blood and marrow transplantation.
- Consultant Pediatric Hematology/Oncology/BMT, with academic affiliations in Riyadh
- Lead investigator on a 23-year single-centre pediatric BMT cohort covering 618 patients and 666 transplants
- Key author on sickle cell transplant series — 129 consecutive pediatric patients transplanted 2006–2020
- Primary interest in pediatric blood and marrow transplantation
- ORCID: 0000-0003-3848-607X
Qualifications & Credentials
Medical Degrees
- MBBS — Information not publicly available.
- Pediatric Residency — SUNY Upstate University Hospital, Syracuse, New York, USA
- Pediatric Hematology/Oncology Fellowship — Information not publicly available.
Fellowships & Special Training
- Pediatric Hematology/Oncology and Bone Marrow Transplant training — SUNY Upstate University Hospital, Syracuse, USA
Certifications & Accreditations
- Saudi Commission for Health Specialties (SCFHS) registration
- Information not publicly available.
Areas of Expertise
Major Conditions Treated
- Acute Lymphoblastic Leukemia (ALL) in children
- Acute Myeloid Leukemia (AML) in children
- Hodgkin and Non-Hodgkin Lymphoma (pediatric)
- Sickle Cell Disease
- Thalassemia
- Aplastic Anemia
- Neuroblastoma (high-risk)
- Essential Thrombocythemia (pediatric)
- Immune deficiencies requiring stem cell transplant
Sub-specialties
- Pediatric Stem Cell Transplantation: Comprehensive experience in matched sibling, unrelated donor, and haploidentical pediatric BMT — a cornerstone of best pediatric cancer treatment in Saudi Arabia.
- Pediatric Leukemia & Lymphoma Care: Multidisciplinary management of relapsed/refractory ALL and AML using clofarabine-based regimens, immunotherapy, and bridge-to-transplant strategies.
- Hemoglobinopathy Transplant Programme: Curative allogeneic HSCT for severe sickle cell disease — a key referral pathway for international patients seeking a pediatric hematology oncology specialist in Riyadh.
Advanced Procedures & Treatments
- Autologous Stem Cell Transplant (pediatric neuroblastoma, lymphoma)
- Allogeneic Stem Cell Transplant (matched sibling, unrelated, haploidentical)
- Pediatric Leukemia Induction and Consolidation Chemotherapy
- Clofarabine-based Salvage Regimens
- Palliative and Symptom Management for Pediatric Oncology
- Bridge-to-HSCT Chemotherapy Protocols
Professional Experience
Current Affiliation
- King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia — Consultant, Pediatric Hematology/Oncology/BMT, Department of Pediatric Hematology/Oncology (MBC 53) (Current)
Past Affiliations
- SUNY Upstate University Hospital, Syracuse, USA — Pediatric Training / Fellowship
Academic & Research Roles
- Faculty contributor — Pediatric Hematology/Oncology training programme, KFSHRC
- Speaker — SIOP Asia 2025 Congress
Key Achievements
- Lead investigator on a 23-year single-centre pediatric BMT database (618 patients, 666 transplants)
- Published single-centre experience of 129 consecutive pediatric sickle cell transplants (2006–2020)
- 20 years of experience in pediatric high-risk neuroblastoma with autologous SCT
- Active member of institutional palliative care research programmes
Awards & Recognitions
National & International Awards
- Information not publicly available.
Professional Memberships
- International Society of Paediatric Oncology (SIOP)
- American Society of Pediatric Hematology/Oncology (ASPHO) — Information not publicly available.
- Saudi Society of Blood Disorders
Research & Publications
Published Papers (Selected)
- Khan S, Siddiqui K, ElSolh H et al. Outcomes of blood and marrow transplantation in children less than 2 years of age: 23 years of experience at a single center. 2022 (PMC10019952).
- Khan S, AlSayyad K, Siddiqui K et al. Pediatric high risk neuroblastoma with autologous stem cell transplant – 20 years of experience. 2021 (PMC8356102).
- Ameen M, Siddiqui K, Khan S et al. Essential Thrombocythemia in Children: A Retrospective Study. J Hematol. 2021. DOI: 10.14740/jh822
- Khan S et al. Physicians' Knowledge, Attitudes, and Perception Toward Pediatric Palliative Care in Saudi Arabia: A National Exploratory Survey. 2023 (PMC10366288).
Ongoing Research & Clinical Interests
- Pediatric hematopoietic stem cell transplantation outcomes
- Sickle cell disease curative therapy
- Pediatric relapsed/refractory leukemia
- Pediatric palliative care and end-of-life care planning
Estimated Treatment Costs
| Procedure / Consultation | Estimated Cost (SAR) | Estimated Cost (USD) |
|---|---|---|
| Pediatric Hematology/Oncology Consultation | SAR 500 – SAR 1,500 | $135 – $400 |
| Pediatric Chemotherapy Cycle | SAR 15,000 – SAR 80,000 | $4,000 – $21,300 |
| Autologous Pediatric SCT | SAR 150,000 – SAR 300,000 | $40,000 – $80,000 |
| Allogeneic Pediatric SCT (matched related) | SAR 300,000 – SAR 550,000 | $80,000 – $146,000 |
| Haploidentical Pediatric SCT | SAR 400,000 – SAR 700,000 | $106,000 – $186,000 |
*Indicative estimates only. Actual costs subject to hospital pricing, case complexity, and insurance. Contact Cancer Rounds for a personalised quote.
Frequently Asked Questions
1. What advanced technologies does Dr. Saadiya Khan use as a Pediatric Oncologist?
Dr. Saadiya Khan uses advanced pediatric treatment protocols including Children's Oncology Group (COG) leukemia regimens, clofarabine-based salvage chemotherapy, and curative allogeneic stem cell transplantation for sickle cell disease and thalassemia. Her centre is the only COG member in the region and provides CAR-T therapy for relapsed/refractory pediatric leukemia. Virtual pediatric second opinions are available via Cancer Rounds.
2. What conditions does Dr. Saadiya Khan specialize in treating?
Dr. Saadiya Khan specialises in pediatric leukemia and lymphoma (ALL, AML, Hodgkin and non-Hodgkin), pediatric stem cell transplantation, sickle cell disease, thalassemia, aplastic anemia, neuroblastoma, and complex hematologic disorders in children — she is regularly sought out as a best pediatric oncology doctor in Riyadh by international families.
3. How do I book an appointment with Dr. Saadiya Khan?
Appointments with Dr. Saadiya Khan can be booked directly through the Cancer Rounds website or by contacting their international patient department for priority scheduling.
4. Can international patients receive treatment from Dr. Saadiya Khan?
Yes. Cancer Rounds provides full assistance for international patients seeking treatment from Dr. Saadiya Khan, including Saudi Arabia medical visa invitation letters, airport transfers, and local accommodation coordination in Riyadh.
5. What support is available for international patients?
International patients benefit from a dedicated concierge service provided by Cancer Rounds, including language interpretation (Arabic, English, and more), financial counselling, and pre-travel virtual consultations to review medical records before arrival in Riyadh.
6. Does Dr. Saadiya Khan offer second opinions as a Pediatric Oncologist?
Yes. Second opinion consultations can be arranged via Cancer Rounds for patients who wish to review their diagnosis or treatment plan with Dr. Saadiya Khan, an expert Pediatric Oncologist in Riyadh, Saudi Arabia.
